These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15540177

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Galectin-3 in differential diagnosis and prognosis of follicular tumors of the thyroid gland].
    Iushkov PV, Antonova SS, Bartolazzi A.
    Arkh Patol; 2004; 66(6):39-42. PubMed ID: 15648166
    [Abstract] [Full Text] [Related]

  • 24. Clinical presentations and outcomes of surgical treatment of follicular variant of the papillary thyroid carcinomas.
    Chang HY, Lin JD, Chou SC, Chao TC, Hsueh C.
    Jpn J Clin Oncol; 2006 Nov; 36(11):688-93. PubMed ID: 17000702
    [Abstract] [Full Text] [Related]

  • 25. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
    Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S.
    Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
    [Abstract] [Full Text] [Related]

  • 26. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
    de Matos PS, Ferreira AP, de Oliveira Facuri F, Assumpção LV, Metze K, Ward LS.
    Histopathology; 2005 Oct; 47(4):391-401. PubMed ID: 16178894
    [Abstract] [Full Text] [Related]

  • 27. Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators.
    Than TH, Swethadri GK, Wong J, Ahmad T, Jamil D, Maganlal RK, Hamdi MM, Abdullah MS.
    Singapore Med J; 2008 Apr; 49(4):333-8. PubMed ID: 18418527
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fine needle aspiration biopsy of follicular thyroid tumors.
    Pauzar B, Staklenac B, Loncar B.
    Coll Antropol; 2010 Mar; 34(1):87-91. PubMed ID: 20432738
    [Abstract] [Full Text] [Related]

  • 30. [Low galectin-3 capacity to discriminate thyroid lesions].
    De-León-Mazariegos R, Canedo-Patzi M, Pérez-Enríquez B, Candanedo-Gonzalez F, Saqui-Salces M, Gamboa-Domínguez A, Rull-Rodrigo JA.
    Rev Invest Clin; 2004 Mar; 56(5):623-8. PubMed ID: 15776867
    [Abstract] [Full Text] [Related]

  • 31. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications.
    Xu XC, el-Naggar AK, Lotan R.
    Am J Pathol; 1995 Sep; 147(3):815-22. PubMed ID: 7677193
    [Abstract] [Full Text] [Related]

  • 32. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS, Teng XD, Ding W, Zhou J, Yao HT, Ying LX, Xu LM.
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [Abstract] [Full Text] [Related]

  • 33. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
    Ito Y, Yoshida H, Tomoda C, Miya A, Kobayashi K, Matsuzuka F, Kakudo K, Kuma K, Miyauchi A.
    Anticancer Res; 2005 Nov; 25(1A):179-82. PubMed ID: 15816536
    [Abstract] [Full Text] [Related]

  • 34. [Fine-needle aspiration biopsy of the thyroid nodule: uses and limitations].
    Hayashi N, Kitaoka M.
    Nihon Rinsho; 2007 Nov; 65(11):2003-7. PubMed ID: 18018562
    [Abstract] [Full Text] [Related]

  • 35. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT, Yang J, Wasserman PG, Bhuiya T, Griffith KA, Michael CW.
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [Abstract] [Full Text] [Related]

  • 36. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor.
    Cui W, Lu X, Zheng S, Ma Y, Liu X, Zhang W.
    Clin Lab; 2012 May; 58(5-6):419-26. PubMed ID: 22783570
    [Abstract] [Full Text] [Related]

  • 37. Galectin-3 immunodetection may improve cytological diagnosis of occult papillary thyroid carcinoma.
    Pisani T, Vecchione A, Giovagnolii MR.
    Anticancer Res; 2004 May; 24(2C):1111-2. PubMed ID: 15154632
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 40. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.